Rutgers Cancer Institute of New Jersey invites candidates to apply for Assistant to Professor level tenure-track faculty positions in pediatric population science, health outcomes, and disparities research. Academic rank is commensurate with qualifications and experience.

The successful behavioral or physician-scientist will join the Pediatric Population Science, Outcomes, and Disparities Research Section in the Division of Pediatric Hematology/Oncology, Department of Pediatrics. The successful applicant will be expected to develop and maintain an innovative, independent, collaborative, and extramurally-funded research program. Area of research interest is open, but we are particularly interested in applicants conducting research in pediatric hematology/oncology health disparities, health equity, cancer survivorship, psychosocial risk and resilience, or community-based research. The Pediatric Hematology/Oncology Program provides comprehensive, state-of-the-art care for children and adolescents with cancer and blood disorders and is a member of the National Cancer Institute supported Children’s Oncology Group (COG), the world’s largest organization devoted exclusively to childhood and adolescent cancer research and clinical trials. The LITE Program at Rutgers Cancer Institute of New Jersey provides long-term evaluation, support, and health education for the growing population of childhood cancer survivors.
The New Jersey Pediatric Hematology/Oncology Research Center of Excellence (NJ PHORCE) was established in 2021 is led by Dr. Peter Cole, the Embrace Kids Endowed Chair and Professor of Pediatric Hematology and Oncology. Its mission is to improve the lives of children diagnosed with cancer or blood disorders through research, training and education, community engagement, and public policy advocacy. To highlight just a few examples, current members of the Center are at the forefront of their research fields: in the biology of DNA repair; in the development of innovative targeted therapies; in preventing treatment-related toxicities; and in understanding disparities in treatment outcomes. Visit us at https://www.cinj.org/research/nj-pediatric-hematology-and-oncology-research-center-excellence-nj-phorce. 

NJ PHORCE is based in the Rutgers Cancer Institute, New Jersey’s only NCI designated comprehensive cancer center. We offer world-class quality cancer care providing the most advanced medicines and treatment options for patients in its New Brunswick facility as well as at its network of hospitals across the state through the partnership with the Robert Wood Johnson Barnabas Health System and University Hospital in Newark. Rutgers Cancer Institute is the only NCI-designated comprehensive cancer center in the state and is easily accessible to New York City, Newark Airport, and Philadelphia by public transportation.
NJ PHORCE is dedicated to growing its research focused on health equity and outcomes among childhood cancer survivors. Rutgers Cancer Institute has a vibrant and active research program in cancer prevention and control, cancer epidemiology and cancer disparities, and a Center for Tobacco Studies at RBHS. There is a strong and growing research program in cancer survivorship in primary care settings at the Department of Family Medicine and Community Health at Rutgers Robert Wood Johnson Medical School. With the integration of Rutgers Cancer Institute into the RWJBarnabas Health System, there are many opportunities for research collaboration and study implementation across New Jersey. Program members also have strong ties with the diverse communities in New Jersey. Rutgers Cancer Institute houses the SEER New Jersey State Cancer Registry, which facilitates research through high quality reporting of cancer cases across the state and rapid case ascertainment of new cancer cases. In addition, Rutgers Cancer Institute has numerous shared resources available to faculty to facilitate research, including: 1) Population Science (DatStat, data collection); 2) Biostatistics; 3) a bio-specimen repository; and 4) precision oncology and access to ORIEN (Oncology Research Information Exchange Network), a shared resource for precision oncology data for epidemiology studies.

Faculty are expected to support the educational goals and activities of the School, and as such will be expected to be involved in teaching activities for students as well as targeted lectures in their area of expertise. For questions on this position or to learn more about our available positions, please contact the Rutgers Cancer Institute Faculty Recruitment Office at cinjcareers@cinj.rutgers.edu.

Candidates must possess a doctoral degree in medicine, psychology, public health, epidemiology, or a health-related profession with a strong publication record. Preference will be given to applicants with an established and extramurally funded research program.

New Jersey’s premier academic health center, Rutgers Biomedical and Health Sciences (RBHS) takes an integrated approach to educating students, providing clinical care, and conducting research, all with the goal of improving human health. Aligned with Rutgers University–New Brunswick and collaborating university wide, RBHS includes eight schools, a behavioral health network, and five centers and institutes that focus on cancer treatment and research, neuroscience, advanced biotechnology and medicine, environmental and occupational health, and health care policy and aging research. Our renowned faculty are teachers, health researchers and providers, and scientists with unparalleled experience who advance medical innovation and provide patient care informed by the latest research findings. We offer an outstanding education and training in medicine, dentistry, pharmacy, public health, nursing, biomedical research, and the full spectrum of allied health careers. An important mission of RBHS is to promote the careers of faculty, staff, and learners. Through this community of healers, scientists, and scholars, Rutgers is equipped as never before to transform lives.

Rutgers Cancer Institute of New Jersey, the state’s only NCI-designated Comprehensive Cancer Center and RWJBarnabas Health, the state’s largest health care delivery system partner to deliver high-quality and sophisticated oncology care to patients close to home. This integrated cancer care model combines the strength of both entities, offering access to the most advanced diagnostic and treatment options for adult and pediatric cancer patients, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy and cardio-oncology. Through the above mentioned partnership and an academic appointment at Rutgers, The State University of New Jersey, unique opportunities exist for collaborations between clinical and research programs, including clinical trials research, cancer chemoprevention, clinical and basic pharmacology, and Phase 1 clinical trials.
Mission
To accelerate scientific discovery focused on understanding cancer, innovating cancer treatment, and improving cancer prevention; to provide outstanding, novel, and compassionate patient care; to provide evidence-based and culturally informed education to physicians, nurses, researchers, staff, and the community; and to achieve cancer health equity in our state through outreach to and engagement of our extraordinarily diverse communities
Vision
Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will advance cancer-focused research worldwide and reduce the burden of cancer in our catchment area. By engaging with and empowering our exceptionally diverse populations, and addressing their questions and fears, we will engender hope for cancer patients and their families and play a critical role in strengthening the fabric of our communities by gaining and protecting their trust and providing access to the outstanding oncology care each person deserves.
Core Values
•Curiosity and Discovery: encouraging an environment of continuous inquiry, creativity, and innovation to generate new knowledge
•Integrity: earning the trust of those we serve and each other through honesty, transparency, accountability, and continuous reflection
•Collaboration: approaching all opportunities with an understanding that together we are better and can achieve more; promoting and maintaining an environment of teamwork and shared knowledge
•Cultivating Diversity: making conscientious efforts in all we do to ensure that our leadership, scientists, clinicians, supporting staff, and trainees reflect the rich diversity of the state of New Jersey and the patient populations and communities we serve
•Respect and Caring: consistently demonstrating caring, compassion, and respect through our words and actions
•Perseverance: maintaining an unwavering commitment to our mission; embracing change, overcoming obstacles, and creating and recreating the path to achieve our goals

Applicants should submit a cover letter detailing how their research would contribute to the Cancer Institute mission, a curriculum vitae, and submit for 3 reference letters.